Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

17 janv. 2012 09h00 HE | Source: Protalex, Inc.

Protalex, Inc. Announces Completion of Dosing Patients in 4th Cohort of Its Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis

SUMMIT, N.J., Jan. 17, 2012 (GLOBE NEWSWIRE) -- Protalex, Inc. (OTCBB:PRTX), a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and...
27 juin 2011 08h00 HE | Source: Protalex, Inc.

Protalex, Inc. Announces Enrollment of First Patients in 4th Cohort of Its Ongoing Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis

SUMMIT, N.J., June 27, 2011 (GLOBE NEWSWIRE) -- Protalex, Inc (OTCBB:PRTX), a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and...
03 mars 2011 08h00 HE | Source: Protalex, Inc.

Protalex, Inc. Announces Enrollment of First Patients in 3rd Cohort of Its Ongoing Phase 1b Dose Escalation Study of PRTX-100 in Patients With Active Rheumatoid Arthritis

SUMMIT, N.J., March 3, 2011 (GLOBE NEWSWIRE) -- Protalex, Inc (OTCBB:PRTX), a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and...
07 déc. 2010 16h05 HE | Source: Protalex, Inc.

Protalex, Inc. Announces 1 for 5 Reverse Stock Split and Preferred Stock Authorization

SUMMIT, N.J., Dec. 7, 2010 (GLOBE NEWSWIRE) -- Protalex, Inc. (OTCBB:PRTX), a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and...
21 oct. 2010 08h30 HE | Source: Protalex, Inc.

Protalex, Inc. Announces Dose Escalation of First Patients in 2nd Cohort of Its Ongoing Phase 1b Study of PRTX-100 in Patients With Active Rheumatoid Arthritis

SUMMIT, N.J., Oct. 21, 2010 (GLOBE NEWSWIRE) -- Protalex, Inc. (OTCBB:PRTX), a clinical stage biopharmaceutical company which is engaged in developing a class of drugs for treating autoimmune and...
20 août 2010 08h00 HE | Source: Protalex, Inc.

Protalex, Inc. Announces Dosing of First Patient in a Phase 1b Study of PRTX-100 in Patients With Active Rheumatoid Arthritis

SUMMIT, N.J., Aug. 20, 2010 (GLOBE NEWSWIRE) -- Protalex, Inc. (OTCBB:PRTX), a clinical stage biopharmaceutical company engaged in developing a class of biopharmaceutical drugs for treating autoimmune...
26 juil. 2005 16h00 HE | Source: Protalex, Inc.

Protalex Appoints Victor S. Sloan, M.D. as Senior Vice President and Chief Medical Officer

NEW HOPE, Pa., July 26, 2005 (PRIMEZONE) -- Protalex, Inc. (OTCBB:PRTX) today announced that Victor S. Sloan, M.D., FACR, FACP has joined the company as Senior Vice President and Chief Medical...